To learn more about the CMS Conference, visit https://cms-conference.com/index.html.

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

SHANGHAI and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the ...

The FDA previously declined to approve UX111 citing CMC-related observations, but the firm is hopeful the agency will approve its new regulatory application.

Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...

The agency outlined the adjustments it's willing to make to "remove barriers and perceived misconceptions" for innovative medicines.

On track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 2026Received ...

“Regulatory flexibility must be tailored for cell and gene therapies,” said FDA Commissioner Marty Makary, M.D., M.P.H. “These are common-sense reforms that will address the unique characteristics of ...

Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Q1 2026 Earnings Call Transcript January 8, 2026 Commercial Metals Company beats earnings expectations. Reported EPS is $1.58 ...